BioCryst Pharmaceuticals | Omløpsmidler

Current Assets Endring Dato
Gilead Sciences USD 16.45B 474M 2023-12
Intra Cellular Therapies USD 667.8M 34.63M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09



BioCryst Pharmaceuticals Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.